FDA schedules adcomms for Entasis' antimicrobial treatment, Intercept's NASH hopeful
The FDA this morning announced two upcoming advisory committee meetings in April and May — with the goal of reviewing two drugs with a lot of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
